Cara Therapeutics Inc (CARA) is around the top of the Biotechnology industry according to InvestorsObserver. CARA received an overall rating of 70, which means that it scores higher than 70 percent of all stocks. Cara Therapeutics Inc also achieved a score of 82 in the Biotechnology industry, putting it above 82 percent of Biotechnology stocks. Biotechnology is ranked 10 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 70 would rank higher than 70 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What’s Happening With Cara Therapeutics Inc Stock Today?
Cara Therapeutics Inc (CARA) stock is up 3.5% while the S&P 500 is unchanged 0% as of 10:30 AM on Thursday, Apr 23. CARA is up $0.55 from the previous closing price of $15.71 on volume of 140,812 shares. Over the past year the S&P 500 is lower by -4.37% while CARA is down -14.60%. CARA lost -$2.49 per share the over the last 12 months.
